Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Pharma Holdings Completes Trial of Generic Crestor®

publication date: Dec 6, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China Pharma Holdings has completed its clinical trials of a generic form of a statin-family cholesterol drug, rosuvastatin. Rosuvastatin is marketed by AstraZeneca as Crestor®. China Pharma intends to obtain SFDA approval for the drug and begin selling it next year in China. More details....

Stock Symbol: (NYSE Amex: CPHI) (NYSE: AZN)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...